CD4 and neoplasm: Surprisingly, we demonstrated that RIME KO decreased the proportion of pro‐tumour M2 macrophages in ESCC xenografts while increasing CD4+ T cells and anti‐tumour M1 macrophages proportion in ESCC xenografts.